shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > News > India News > Article > Govt will achieve goal of tuberculosis free India by 2025 Health Min

Govt will achieve goal of tuberculosis free India by 2025: Health Min

Updated on: 18 August,2020 11:08 AM IST  |  New Delhi
ANI |

The Union Health Minister expressed confidence that the governments boost to health infrastructure through Ayushman Bharat scheme would similarly eradicate diseases like Kala-azar and leprosy and push the maternal mortality rate to near zero

Govt will achieve goal of tuberculosis free India by 2025: Health Min

Dr Harsh Vardhan

Union Health Minister Dr Harsh Vardhan on Monday expressed confidence that the government will achieve the goal of tuberculosis (TB) free India by 2025 as resource allocation for the disease has witnessed a four-fold increase in the last five years.


Vardhan made these remarks while virtually addressing the inaugural session of the two-day Public Health Conference by Confederation of Indian Industry (CII).



"This pandemic has given us a chance to revisit and structurally re-imagine a robust public health infrastructure for our country. The country's capacity to turn government schemes into a broader social movement that saw the complete eradication of smallpox and polio from a time when India contributed 60 per cent of the global cases of polio gives me hope that the Prime's Ministers goal of a tuberculosis free India by 2025 would be similarly achieved with the help of industry leaders and the CII," Vardhan said.


"Resource allocation for TB in India has witnessed a four-fold increase in the last five years. The Prime Minister had initiated a big survey for the detection of TB cases upon taking office in 2014 itself. Every patient of TB and even those with multi-drug resistant TB are treated free as the entire cost is borne by the government while doctors are incentivised to report TB cases," he added.

On the 'TB Free Workplaces' campaign, Vardhan said, "India with nearly 26.4 lakh tuberculosis cases continues to have the largest share of the global TB burden. The economic burden of TB is huge in terms of lives, money and workdays lost as it disproportionately affects the poor who live in unsanitary conditions and are deprived of calories".

The Union Health Minister expressed confidence that the government's boost to health infrastructure through Ayushman Bharat scheme would similarly eradicate diseases like Kala-azar and leprosy and push the maternal mortality rate to near zero.

Minister of State for Health and Family Welfare Ashwini Kumar Choubey and Member (Health) NITI Aayog Dr Vinod K. Paul also participated digitally. A virtual exhibition on healthcare and the "CII TB Free Workplaces Campaign" was launched and the "CII Public Health Report" was released in their presence.

Dr Randeep Guleria, Director, All India Institute of Medical Sciences in his capacity as Chairman - CII Public Health Council and Chandrajit Banerjee, Director General, Confederation of Indian Industry (CII) were also digitally present on the occasion.

Keep scrolling to read more news

Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK